Literature DB >> 8160476

Low-density lipoprotein oxidation and the pathogenesis of atherosclerosis.

A Chait.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8160476      PMCID： PMC1022336     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  19 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking.

Authors:  D Harats; M Ben-Naim; Y Dabach; G Hollander; E Havivi; O Stein; Y Stein
Journal:  Atherosclerosis       Date:  1990-11       Impact factor: 5.162

3.  Low density lipoprotein undergoes oxidative modification in vivo.

Authors:  W Palinski; M E Rosenfeld; S Ylä-Herttuala; G C Gurtner; S S Socher; S W Butler; S Parthasarathy; T E Carew; D Steinberg; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Lipoproteins containing apo B extracted from human aortas. Structure and function.

Authors:  H F Hoff; R E Morton
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

5.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

Authors:  J P Kane; M J Malloy; T A Ports; N R Phillips; J C Diehl; R J Havel
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

6.  Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

Authors:  L Cashin-Hemphill; W J Mack; J M Pogoda; M E Sanmarco; S P Azen; D H Blankenhorn
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

7.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

Review 8.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

9.  Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology.

Authors:  K F Gey; P Puska; P Jordan; U K Moser
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

10.  Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

Authors:  H C Boyd; A M Gown; G Wolfbauer; A Chait
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307
View more
  1 in total

1.  Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle.

Authors:  Richard W Browne; Michael S Bloom; Enrique F Schisterman; Kathy Hovey; Maurizio Trevisan; Chengqing Wu; Aiyi Liu; Jean Wactawski-Wende
Journal:  Biomarkers       Date:  2008-03       Impact factor: 2.658
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.